DOI•
Vive la DIFF-érence!
08 May 2013-Vol. 18, Iss: 2, pp 114-115
About: The article was published on 2013-05-08 and is currently open access. It has received 2 citations till now.
Citations
More filters
Georgetown University1, Wake Forest University2, Association of American Medical Colleges3, American Diabetes Association4, Federation of American Societies for Experimental Biology5, University of Texas at Austin6, Memorial Hospital of South Bend7, University of Maryland, College Park8, Howard University9, Mayo Clinic10, Louisiana State University11, Rockefeller University12, Pfizer13, University of Calgary14, Saint Louis University15, Northwestern University16
TL;DR: The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health.
Abstract: The U.S. National Institutes of Health (NIH) announced last May that steps will be taken to address the over-reliance on male cells and animals in preclinical research. To further address this announcement, in September 2014, scientists with varying perspectives came together at Georgetown University to discuss the following questions. (1) What metrics should the NIH use to assess tangible progress on policy changes designed to address the over-reliance on male cells and animals in preclinical research? (2) How effective can education be in reducing the over-reliance on male cells and animals in preclinical research and what educational initiatives sponsored by the NIH would most likely effect change? (3) What criteria should the NIH use to determine rigorously defined exceptions to the future proposal requirement of a balance of male and female cells and animals in preclinical studies? (4) What additional strategies in addition to proposal requirements should NIH use to reduce the overreliance of male cells and animals in preclinical research? The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health. We offer our recommendations to aid the NIH as it selects, implements, monitors, and optimizes strategies to correct the over-reliance on male cells and animals in preclinical research.
60 citations
TL;DR: In this article, the question of how designers can be supported to deliberately facilitate positive emotional experiences is addressed, and the authors provide an overview of the role of designers in this process.
Abstract: Central to the present paper is the question of how designers can be supported to deliberately facilitate positive emotional experiences. Related to this, the paper provides an overview of the rese...
17 citations
Cites background from "Vive la DIFF-érence!"
...Design for positive emotions as a means of fostering user well-being A considerable amount of the literature on positive psychology has proven that positive emotions are inherently associated with people’s well-being (e.g., Kirby et al. 2014, Cohn et al. 2009, Seligman 2011)....
[...]
...There are considerable evidences that positive emotions play the critical roles in perception, thoughts, behaviour and, by extension, improved wellbeing (see Tugade, Shiota, and Kirby et al. 2014, for an overview)....
[...]
References
More filters
Georgetown University1, Wake Forest University2, Association of American Medical Colleges3, American Diabetes Association4, Federation of American Societies for Experimental Biology5, University of Texas at Austin6, Memorial Hospital of South Bend7, University of Maryland, College Park8, Howard University9, Mayo Clinic10, Louisiana State University11, Rockefeller University12, Pfizer13, University of Calgary14, Saint Louis University15, Northwestern University16
TL;DR: The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health.
Abstract: The U.S. National Institutes of Health (NIH) announced last May that steps will be taken to address the over-reliance on male cells and animals in preclinical research. To further address this announcement, in September 2014, scientists with varying perspectives came together at Georgetown University to discuss the following questions. (1) What metrics should the NIH use to assess tangible progress on policy changes designed to address the over-reliance on male cells and animals in preclinical research? (2) How effective can education be in reducing the over-reliance on male cells and animals in preclinical research and what educational initiatives sponsored by the NIH would most likely effect change? (3) What criteria should the NIH use to determine rigorously defined exceptions to the future proposal requirement of a balance of male and female cells and animals in preclinical studies? (4) What additional strategies in addition to proposal requirements should NIH use to reduce the overreliance of male cells and animals in preclinical research? The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health. We offer our recommendations to aid the NIH as it selects, implements, monitors, and optimizes strategies to correct the over-reliance on male cells and animals in preclinical research.
60 citations
TL;DR: In this article, the question of how designers can be supported to deliberately facilitate positive emotional experiences is addressed, and the authors provide an overview of the role of designers in this process.
Abstract: Central to the present paper is the question of how designers can be supported to deliberately facilitate positive emotional experiences. Related to this, the paper provides an overview of the rese...
17 citations